• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, April 11, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

New study questions effectiveness of invasive procedures for chronic pain

Bioengineer by Bioengineer
September 12, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Alexandria, VA (September 12, 2018¬) — An extensive review of 25 randomized clinical trials found "little evidence" that invasive surgery was more effective than sham or placebo procedures in reducing chronic pain. The study was published in the journal Pain Medicine.

"Our findings raise several questions for clinicians, researchers, and policy-makers. First, can we justify widespread use of these procedures without rigorous testing?" said the lead author, Wayne B. Jonas, MD, clinical Professor of Family Medicine at the Uniformed Services University and at Georgetown University School of Medicine. He is also the executive director of Samueli Integrative Health Programs.

An estimated 100 million Americans suffer from chronic pain, with costs estimated at more than $500 billion annually. With the development of new minimally invasive procedures, Americans spent an estimated $45 billion on surgery for chronic low back pain and $41 billion for arthroplasty for chronic knee pain in 2014, the study said. Non-opioid treatments, like surgery, are being increasingly used.

But researchers concluded that "evidence does not support the use of invasive procedures as compared with sham procedures for patients with chronic back or knee pain. Given their high costs and safety concerns, more rigorous studies are required before invasive procedures are routinely used for patients with chronic pain."

The findings are based on a systematic review of studies from 28 publications between 1959 and 2013 involving surgeries on 2,000 patients. Procedures performed included open surgeries, arthroscopic, endoscopic, laparoscopic, heart catheterization, radiofrequency, laser, and other interventions. In each study, researchers had also performed sham procedures on a control group where they faked the invasive procedure by omitting the step believed to be therapeutically necessary. They then compared reduction in pain intensity, disability, health-related quality of life, use of medication, adverse events, and other factors at various time periods after the procedures. Patients did not know which intervention (real or sham) they had and in most cases, evaluators were also blind to which procedure a patient received.

Outcomes varied across the studies: in 14 studies that had sufficient data, the risk of any adverse event was significantly higher with surgery (12%) than with the sham group (4%.) Globally, the studies appeared to favor active treatment over sham treatment; however, the quality of the studies varied and the majority reported small effects. Overall, the reduction in disability post-procedure did not differ between the two groups at three months or at six months. A meta-analysis on outcomes in seven studies of low back pain and three on knee osteoarthritis showed no difference in pain at six months compared with sham procedures.

The study notes that many types of invasive procedures are marketed, used, and paid for without evidence from rigorous study designs involving randomization, blinding, and placebo.

"Because of the high costs and risks associated with these procedures and the vast number of people who are exposed to those risks, we need to focus on building evidence to support these methods," said Jonas.

Authors noted several limitations in their meta-analysis: there were few studies of any one pain condition, resulting in substantial heterogeneity across populations and interventions; many types of invasive procedures for pain have not been subjected to sham-controlled studies; and none of the studies were double-blind because clinicians were aware of which procedures were actual vs. sham.

The study was funded by the Samueli Institute, a nonprofit research organization dedicated to investigating the safety, effectiveness, and integration of healing-oriented practices to allow for evidence-based decision-making.

###

About Samueli Integrative Health Programs

Samueli Integrative Health Programs works to empower patients and doctors by providing solutions that enhance health, prevent disease, and relieve chronic pain.

Henry & Susan Samueli, leaders in support of integrative health, are focused on a new effort to help physicians and patients gain information and resources that add health back into health care. The effort is led by Wayne Jonas, MD, a family physician, researcher, and author of hundreds of articles on health and healing.

Media Contact

Kathleen Petty
[email protected]
202-868-4013

Spotlighting vital issues, organizations and individuals.

http://dx.doi.org/10.1093/pm/pny154

Share16Tweet7Share2ShareShareShare1

Related Posts

Older Adults’ Social Support: Insights from Tamil Nadu

April 11, 2026

Examining Tasks and Risks in Biosolids Land Application

April 11, 2026

Single-Cell Map Reveals Immune Crosstalk in Cholangitis

April 11, 2026

Berry Gold Nanoparticles Trigger Cancer Cell Death and Immune Response

April 11, 2026
Please login to join discussion

POPULAR NEWS

  • Boosting Breast Cancer Risk Prediction with Genetics

    47 shares
    Share 19 Tweet 12
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    44 shares
    Share 18 Tweet 11
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1012 shares
    Share 400 Tweet 250
  • Revolutionary Theory Transforms Quantum Perspective on the Big Bang

    41 shares
    Share 16 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Updated Alcohol Guidelines Reveal Cancer Risk Burden

PARP Inhibitors: Breast Cancer’s Breakthrough and Resistance

Older Adults’ Social Support: Insights from Tamil Nadu

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.